Dashboard
Manage Tickers

JAZZJazz Pharmaceuticals plc

Nasdaq jazzpharma.com


$ 107.15 $ -0.47 (-0.44 %)    

Monday, 24-Jun-2024 09:32:17 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 478.72 $ -0.45 (-0.09 %)
DIA $ 392.46 $ 0.00 (0 %)
SPY $ 544.41 $ 0.02 (0 %)
TLT $ 93.99 $ 0.24 (0.25 %)
GLD $ 215.72 $ 0.13 (0.06 %)
$ 107.97
$ 107.62
$ 0.00 x 0
$ 107.95 x 209
$ 107.15 - $ 107.73
$ 103.01 - $ 146.70
1,600,867
na
6.75B
$ 0.69
$ 20.41
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-02-2024 03-31-2024 10-Q
2 02-28-2024 12-31-2023 10-K
3 11-08-2023 09-30-2023 10-Q
4 08-09-2023 06-30-2023 10-Q
5 05-10-2023 03-31-2023 10-Q
6 03-01-2023 12-31-2022 10-K
7 11-09-2022 09-30-2022 10-Q
8 08-03-2022 06-30-2022 10-Q
9 05-04-2022 03-31-2022 10-Q
10 03-01-2022 12-31-2021 10-K
11 11-09-2021 09-30-2021 10-Q
12 08-03-2021 06-30-2021 10-Q
13 05-04-2021 03-31-2021 10-Q
14 02-23-2021 12-31-2020 10-K
15 11-02-2020 09-30-2020 10-Q
16 08-04-2020 06-30-2020 10-Q
17 05-05-2020 03-31-2020 10-Q
18 02-25-2020 12-31-2019 10-K
19 11-05-2019 09-30-2019 10-Q
20 08-06-2019 06-30-2019 10-Q
21 05-07-2019 03-31-2019 10-Q
22 02-26-2019 12-31-2018 10-K
23 11-06-2018 09-30-2018 10-Q
24 08-07-2018 06-30-2018 10-Q
25 05-08-2018 03-31-2018 10-Q
26 02-27-2018 12-31-2017 10-K
27 11-07-2017 09-30-2017 10-Q
28 08-08-2017 06-30-2017 10-Q
29 05-09-2017 03-31-2017 10-Q
30 02-28-2017 12-31-2016 10-K
31 11-08-2016 09-30-2016 10-Q
32 08-09-2016 06-30-2016 10-Q
33 05-10-2016 03-31-2016 10-Q
34 02-23-2016 12-31-2015 10-K
35 11-09-2015 09-30-2015 10-Q
36 08-05-2015 06-30-2015 10-Q
37 05-07-2015 03-31-2015 10-Q
38 02-24-2015 12-31-2014 10-K
39 11-04-2014 09-30-2014 10-Q
40 08-05-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

why-is-jazz-pharmaceuticals-stock-trading-lower-on-thursday
Why Is Jazz Pharmaceuticals Stock Trading ...
06/20/2024 16:29:49

Jazz Pharmaceuticals announced Phase 2b trial results for suvecaltamide (JZP385) in essential tremor patients, revealing no sig...

needham-maintains-buy-on-jazz-pharmaceuticals-lowers-price-target-to-210
Needham Maintains Buy on Jazz Pharmaceutic...
06/20/2024 15:20:43

Needham analyst Ami Fadia maintains Jazz Pharmaceuticals (NASDAQ:JAZZ) with a Buy and lowers the price target from $222 to $...

jazz-pharmaceuticals-suvecaltamide-jzp385-did-not-achieve-statistical-significance-at-30mg-versus-placebo-on-primary-endpoint-of-change-from-baseline-to-week-12-on-essential-tremor-rating-assessment-scale-modified-composite-outcome-score
Jazz Pharmaceuticals' Suvecaltamide (JZP38...
06/20/2024 11:56:35

The trial also did not meet On Key Secondary Endpoint Of Clinical Global Impression-severity Scale

this-old-dominion-analyst-begins-coverage-on-a-bullish-note-here-are-top-5-initiations-for-wednesday
This Old Dominion Analyst Begins Coverage ...
06/05/2024 13:02:16

decoding-12-analyst-evaluations-for-jazz-pharmaceuticals
Decoding 12 Analyst Evaluations For Jazz P...
06/05/2024 13:00:27

goldman-sachs-initiates-coverage-on-jazz-pharmaceuticals-with-buy-rating-announces-price-target-of-169
Goldman Sachs Initiates Coverage On Jazz P...
06/05/2024 12:24:46

Goldman Sachs analyst Madhu Kumar initiates coverage on Jazz Pharmaceuticals (NASDAQ:JAZZ) with a Buy rating and announces P...

reported-saturday-jazz-pharmaceuticals-showcased-updated-survival-data-from-the-herizon-btc-01-trial-of-zanidatamab-in-her2-positive-biliary-tract-cancer-at-asco-2024
Reported Saturday, Jazz Pharmaceuticals Sh...
06/03/2024 08:57:06

Zanidatamab demonstrated a median overall survival (OS) of 15.5 months in patients with centrally confirmed immunohistochemistr...

jazz-pharmas-zanidatamab-granted-fda-priority-review-for-advanced-her2-positive-biliary-tract-cancer
Jazz Pharma's Zanidatamab Granted FDA Prio...
05/29/2024 11:47:55

Jazz Pharmaceuticals plc (NASDAQ:JAZZ) today announced that the U.S. Food and Drug Administration (FDA) has accepted and grante...

jazz-pharmaceuticals-and-life-science-cares-collaborate-for-social-impact-through-employee-volunteerism
Jazz Pharmaceuticals And Life Science Care...
05/22/2024 12:05:29

cannabis-meets-prescription-drugs-steroids-and-ketamine-in-schedule-iii-what-it-means-key-stocks-to-watch
Cannabis Meets Prescription Drugs, Steroid...
05/18/2024 14:19:14

President Joe Biden's administration is moving to reschedule cannabis from Schedule I to Schedule III under the Controlled ...

10-health-care-stocks-with-whale-alerts-in-todays-session
10 Health Care Stocks With Whale Alerts In...
05/15/2024 17:35:22

hc-wainwright--co-reiterates-buy-on-jazz-pharmaceuticals-maintains-200-price-target
HC Wainwright & Co. Reiterates Buy on Jazz...
05/03/2024 19:22:26

HC Wainwright & Co. analyst Oren Livnat reiterates Jazz Pharmaceuticals (NASDAQ:JAZZ) with a Buy and maintains $200 pric...

barclays-maintains-overweight-on-jazz-pharmaceuticals-lowers-price-target-to-200
Barclays Maintains Overweight on Jazz Phar...
05/03/2024 14:30:33

Barclays analyst Balaji Prasad maintains Jazz Pharmaceuticals (NASDAQ:JAZZ) with a Overweight and lowers the price target fr...

demystifying-jazz-pharmaceuticals-insights-from-15-analyst-reviews
Demystifying Jazz Pharmaceuticals: Insight...
05/02/2024 14:00:36

needham-reiterates-buy-on-jazz-pharmaceuticals-maintains-222-price-target
Needham Reiterates Buy on Jazz Pharmaceuti...
05/02/2024 10:35:13

Needham analyst Ami Fadia reiterates Jazz Pharmaceuticals (NASDAQ:JAZZ) with a Buy and maintains $222 price target.

jazz-pharmaceuticals-affirms-2024-revenue-guidance-4b-42b
Jazz Pharmaceuticals Affirms 2024 Revenue ...
05/01/2024 21:08:45

jazz-pharmaceuticals-q1-2024-adj-eps-268-misses-418-estimate-sales-901983m-miss-953896m-estimate
Jazz Pharmaceuticals Q1 2024 Adj EPS $2.68...
05/01/2024 21:08:07

Jazz Pharmaceuticals (NASDAQ:JAZZ) reported quarterly earnings of $2.68 per share which missed the analyst consensus estimate o...

breaking-down-jazz-pharmaceuticals-15-analysts-share-their-views
Breaking Down Jazz Pharmaceuticals: 15 Ana...
04/10/2024 14:01:22

cantor-fitzgerald-reiterates-overweight-on-jazz-pharmaceuticals-maintains-180-price-target
Cantor Fitzgerald Reiterates Overweight on...
04/10/2024 13:37:31

Cantor Fitzgerald analyst Charles Duncan reiterates Jazz Pharmaceuticals (NASDAQ:JAZZ) with a Overweight and maintains $180 ...

correction-jazz-pharmaceuticals-completes-zanidatamab-biologics-license-application-for-previously-treated-her2-positive-metastatic-biliary-tract-cancer
CORRECTION: Jazz Pharmaceuticals Completes...
04/02/2024 12:00:28

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

06/28/2024 Malibu Boats, Inc. (MBUU)
07/01/2024 Globe Life Inc. f/k/a Torchmark Corporation (GL)
07/01/2024 Equinix, Inc. (EQIX)
07/02/2024 Intel Corporation (INTC)
07/05/2024 AXT, Inc. (AXTI)
07/05/2024 Altimmune, Inc. (ALT)
07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)

NEW CASE INVESTIGATION

AnaptysBio Inc (ANAB)